SCHEMBL23986229

SCHEMBL23986229

CNc1cccc2sc(N)nc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.61
▸ LMNA P02545 4/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ PDPK1 O15530 1/20 0.56
▸ PDE10A Q9Y233 1/20 0.56
▸ TDP1 Q9NUW8 3/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.40
▸ APP P05067 1/20 0.38
▸ MAPT P10636 5/20 0.37
▸ GAA P10253 4/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ PKM P14618 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ NUDT1 P36639 1/20 0.36
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15893874 0.80 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2TDP1HSD17B10
Hydrochloric Acid SCHEMBL27518762 0.79 ALDH1A1 (0.40) ALDH1A1LMNASMN1; SMN2TDP1HSD17B10
SCHEMBL94937 0.76 ALDH1A1 (1.00) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A
SCHEMBL29992706 0.76 ALDH1A1 (1.00) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A
SCHEMBL969167 0.75 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A
Bromide SCHEMBL11833484 0.74 ALDH1A1 (0.96) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A
Hydrochloric Acid SCHEMBL11081862 0.74 ALDH1A1 (0.96) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A
SCHEMBL21100004 0.74 HSD17B10 (0.64) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A
Hydrochloric Acid SCHEMBL28787382 0.73 ALDH1A1 (0.63) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A
SCHEMBL28878448 0.73 ALDH1A1 (0.62) ALDH1A1LMNASMN1; SMN2PDPK1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022148422-A1 BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF BEIGENE, LTD. (KY) 2022-07-14 — — WO disclosed
WO-2022095960-A1 KRAS INHIBITORS FOR TREATMENT OF CANCERS 泰励生物科技(上海)有限公司 2022-05-12 — — WO disclosed
WO-2021218110-A1 BENZOTHIAZOLYL BIARYL COMPOUND, AND PREPARATION METHOD AND USE 上海凌达生物医药有限公司 2021-11-04 — — WO disclosed
Send feedback